FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2770792022> ?p ?o ?g. }

• W2770792022 endingPage "422" @default.
• W2770792022 startingPage "405" @default.
• W2770792022 abstract "Hepatocellular carcinoma (HCC) is the second leading cause of cancer deaths worldwide largely due to lack of effective targeted drugs to simultaneously block multiple cancer-driving pathways. The identification of all-trans retinoic acid (ATRA) as a potent Pin1 inhibitor provides a promising candidate for HCC targeted therapy because Pin1 is overexpressed in most HCC and activates numerous cancer-driving pathways. However, the efficacy of ATRA against solid tumors is limited due to its short half-life of 45min in humans. A slow-releasing ATRA formulation inhibits solid tumors such as HCC, but can be used only in animals. Here, we developed a one-step, cost-effective route to produce a novel biocompatible, biodegradable, and non-toxic controlled release formulation of ATRA for effective HCC therapy. We used supercritical carbon dioxide process to encapsulate ATRA in largely uniform poly L-lactic acid (PLLA) microparticles, with the efficiency of 91.4% and yield of 68.3%, and ~4-fold higher Cmax and AUC over the slow-releasing ATRA formulation. ATRA-PLLA microparticles had good biocompatibility, and significantly enhanced the inhibitory potency of ATRA on HCC cell growth, improving IC50 by over 3-fold. ATRA-PLLA microparticles exerted its efficacy likely through degrading Pin1 and inhibiting multiple Pin1-regulated cancer pathways and cell cycle progression. Indeed, Pin1 knock-down abolished ATRA inhibitory effects on HCC cells and ATRA-PLLA did not inhibit normal liver cells, as expected because ATRA selectively inhibits active Pin1 in cancer cells. Moreover ATRA-PLLA microparticles significantly enhanced the efficacy of ATRA against HCC tumor growth in mice through reducing Pin1, with a better potency than the slow-releasing ATRA formulation, consistent with its improved pharmacokinetic profiles. This study illustrates an effective platform to produce controlled release formulation of anti-cancer drugs, and ATRA-PLLA microparticles might be a promising targeted drug for HCC therapy as PLLA is biocompatible, biodegradable and nontoxic to humans." @default.
• W2770792022 created "2017-12-04" @default.
• W2770792022 creator A5007404893 @default.
• W2770792022 creator A5009318195 @default.
• W2770792022 creator A5011873891 @default.
• W2770792022 creator A5016017942 @default.
• W2770792022 creator A5030637649 @default.
• W2770792022 creator A5033308608 @default.
• W2770792022 creator A5052135528 @default.
• W2770792022 creator A5068519510 @default.
• W2770792022 creator A5070096703 @default.
• W2770792022 creator A5075047021 @default.
• W2770792022 creator A5080380867 @default.
• W2770792022 creator A5080932283 @default.
• W2770792022 creator A5086498635 @default.
• W2770792022 creator A5090113807 @default.
• W2770792022 date "2018-01-01" @default.
• W2770792022 modified "2023-10-15" @default.
• W2770792022 title "A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways" @default.
• W2770792022 cites W1038682962 @default.
• W2770792022 cites W1539454494 @default.
• W2770792022 cites W1639582946 @default.
• W2770792022 cites W1757407923 @default.
• W2770792022 cites W1762968278 @default.
• W2770792022 cites W1832844087 @default.
• W2770792022 cites W1964224609 @default.
• W2770792022 cites W1964898641 @default.
• W2770792022 cites W1971485756 @default.
• W2770792022 cites W1977587477 @default.
• W2770792022 cites W1978144511 @default.
• W2770792022 cites W1979108272 @default.
• W2770792022 cites W1980462590 @default.
• W2770792022 cites W1983409515 @default.
• W2770792022 cites W1985131241 @default.
• W2770792022 cites W1991199800 @default.
• W2770792022 cites W1999054269 @default.
• W2770792022 cites W2009216651 @default.
• W2770792022 cites W2015554398 @default.
• W2770792022 cites W2016132261 @default.
• W2770792022 cites W2017869832 @default.
• W2770792022 cites W2024009971 @default.
• W2770792022 cites W2025438038 @default.
• W2770792022 cites W2026383746 @default.
• W2770792022 cites W2027048152 @default.
• W2770792022 cites W2028382049 @default.
• W2770792022 cites W2029928472 @default.
• W2770792022 cites W2031588422 @default.
• W2770792022 cites W2036800762 @default.
• W2770792022 cites W2037715397 @default.
• W2770792022 cites W2041352318 @default.
• W2770792022 cites W2042376976 @default.
• W2770792022 cites W2043763280 @default.
• W2770792022 cites W2044433401 @default.
• W2770792022 cites W2047440233 @default.
• W2770792022 cites W2054242277 @default.
• W2770792022 cites W2061149851 @default.
• W2770792022 cites W2063346644 @default.
• W2770792022 cites W2063394559 @default.
• W2770792022 cites W2067831243 @default.
• W2770792022 cites W2071083599 @default.
• W2770792022 cites W2072304559 @default.
• W2770792022 cites W2077813812 @default.
• W2770792022 cites W2079780875 @default.
• W2770792022 cites W2079793032 @default.
• W2770792022 cites W2082506628 @default.
• W2770792022 cites W2084402367 @default.
• W2770792022 cites W2084925214 @default.
• W2770792022 cites W2086225584 @default.
• W2770792022 cites W2089155498 @default.
• W2770792022 cites W2091342503 @default.
• W2770792022 cites W2095001952 @default.
• W2770792022 cites W2098647609 @default.
• W2770792022 cites W2100086304 @default.
• W2770792022 cites W2100113160 @default.
• W2770792022 cites W2104592847 @default.
• W2770792022 cites W2105651504 @default.
• W2770792022 cites W2109556169 @default.
• W2770792022 cites W2117692326 @default.
• W2770792022 cites W2129876170 @default.
• W2770792022 cites W2134001087 @default.
• W2770792022 cites W2151656902 @default.
• W2770792022 cites W2154945153 @default.
• W2770792022 cites W2162901606 @default.
• W2770792022 cites W2167573033 @default.
• W2770792022 cites W2170947784 @default.
• W2770792022 cites W2260775954 @default.
• W2770792022 cites W2290516573 @default.
• W2770792022 cites W2297822018 @default.
• W2770792022 cites W2342270837 @default.
• W2770792022 cites W2416176918 @default.
• W2770792022 cites W2419193153 @default.
• W2770792022 cites W2419248317 @default.
• W2770792022 cites W2443384920 @default.
• W2770792022 cites W2465950095 @default.
• W2770792022 cites W2470233012 @default.
• W2770792022 cites W2478808164 @default.
• W2770792022 cites W2527474055 @default.
• W2770792022 cites W2572278914 @default.

• next